Navigation Links
New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
Date:9/18/2007

Reinforces Importance of DHA/ARA in Infant Diet

EVANSVILLE, Ind., Sept. 18 /PRNewswire-FirstCall/ -- A recently published study of 4 year olds who had been fed Enfamil LIPIL infant formula exclusively for their first 17 weeks of life has become the longest-term analysis of its kind to demonstrate breastfed-equivalent visual and IQ outcomes among formula- fed infants.(1) The study, which appeared in the journal Early Human Development, was funded by a grant from the National Institutes of Health.

"What this study means for parents is that we now have even longer-term evidence that DHA and ARA supplementation at the levels in Enfamil LIPIL is associated with visual acuity and brain development benefits similar to breast milk," said Deborah Diersen-Schade, Ph.D., a research fellow at Mead Johnson Nutritionals. Previously, brain and eye development outcomes similar to breast milk had been followed in the same group of infants out to 18 months of age.(2, 3)

DHA (docosahexaenoic acid) and ARA (arachidonic acid) are nutrients known as "long-chain polyunsaturated fatty acids (LCPUFA)" that are present in breast milk.

They are critical for development of the eyes, brain and central nervous system. They begin accumulating in the infant's tissues during gestation, especially during the third trimester. Recent evidence suggests that they continue to support the development of visual acuity throughout the first full year of life.(4)

Dr. Diersen-Schade emphasized that the new study addresses two other issues that are important for parents and physicians -- those issues being DHA and ARA levels and control group outcomes.

"The levels of DHA and ARA in Enfamil LIPIL were derived from our evaluation of the levels of both nutrients in human milk worldwide," she said. "The results that Dr. Birch and her colleagues obtained from this analysis as well as earlier positive results from previous studies are based on formulas with DHA at
'/>"/>

SOURCE Mead Johnson
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... Confirms Role of AMBIEN CR in Effectively Managing Insomnia to ... Improve Quantity and Quality of Work Performance, BRIDGEWATER, ... study that showed patients with chronic,insomnia who were treated with ... experienced significant improvements in two,key parameters of work performance - ...
... - favorable pharmacokinetic and safety data observed in first ... trial of novel Fleximer(TM) anticancer ... a cancer,therapeutics company, announced interim results of a Phase ... with advanced solid tumors.,The data was presented by Edward ...
Cached Medicine Technology:New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 4Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 2Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 3
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
(Date:1/22/2015)... 2015 Compare-autoinsurance.org has released a new blog post ... auto insurance policy . , Some types of vehicles ... check the newly released blog post to see if their vehicle ... damaged vehicles are some of the cars that cannot be covered ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... personal injury lawyer reacts to hard-hitting New York Times investigative series that ... New York state. , ... New York, NY (PRWEB) April 7, 2009 ... of their own much-needed workers, compensation claim rather than face ...
... encryption services DALLAS, April 7 Zix Corporation ... in email encryption services, today announced that Houston ... three-year contract for the company,s email encryption services.ZixCorp ... ensure the secure handling of confidential information. The ...
... DARTMOUTH, NS, April 7 /PRNewswire/ - A new study ... AACR (American Association for Clinical Cancer Research), shows diets ... acid) may decrease the risk of prostate cancer. This ... with a genetic tendency towards developing the disease. , ...
... Andersen Consulting and Siebel Systems involved with new independent ... new company aimed at promoting and supporting a home-centered ... George T. Shaheen as a member of the company,s ... George has accepted a position on our Board and ...
... ... Atlanta, GA & Las Vegas, NV (PRWEB) April 7, ... outsourcing, today announced it has formed a strategic relationship with Oval ... comprehension and decision making of Intellectual Property landscapes. The solution ...
... that female noses are more sensitive to body odors , , ... fancy colognes and detect male body odor, but men don,t ... speculate that women may be more sensitive to biologically relevant ... a mate. , "It is quite difficult to block a ...
Cached Medicine News:Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 2Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 3Health News:Workers Comp Troubles Making You Sick? New York Personal Injury Lawyers Might Just Have the Cure 4Health News:Zix Corporation Selected by Houston Healthcare for Email Encryption Service 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 2Health News:Omega-3 EPA/DHA May Decrease Risk of Developing Prostate Cancer 3Health News:George T. Shaheen Joins Board of Directors at Univita Health 2Health News:UnitedLex Announces Strategic Alliance with Oval Ideas to Enable Superior Patent Analytics 2Health News:What's That Smell? Ask a Woman, Not a Man 2
...
...
...
... Anterior Cervical Plate System allows for ... along slots in the plate, while ... end of the construct. In addition, ... pre-compression features that enable the surgeon ...
Medicine Products: